ESTA vs. EAR, ENOV, CDRE, AVNS, ZJYL, SMTI, INGN, LAKE, CLGN, and APT
Should you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include Eargo (EAR), Enovis (ENOV), Cadre (CDRE), Avanos Medical (AVNS), Jin Medical International (ZJYL), Sanara MedTech (SMTI), Inogen (INGN), Lakeland Industries (LAKE), CollPlant Biotechnologies (CLGN), and Alpha Pro Tech (APT).
Eargo (NASDAQ:EAR) and Establishment Labs (NASDAQ:ESTA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.
Eargo has a beta of 1.5, meaning that its share price is 50% more volatile than the S&P 500. Comparatively, Establishment Labs has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500.
80.5% of Eargo shares are owned by institutional investors. Comparatively, 72.9% of Establishment Labs shares are owned by institutional investors. 0.8% of Eargo shares are owned by insiders. Comparatively, 11.4% of Establishment Labs shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Establishment Labs has a consensus price target of $55.00, suggesting a potential upside of 6.59%. Given Eargo's higher probable upside, analysts plainly believe Establishment Labs is more favorable than Eargo.
In the previous week, Eargo had 3 more articles in the media than Establishment Labs. MarketBeat recorded 6 mentions for Eargo and 3 mentions for Establishment Labs. Eargo's average media sentiment score of 0.65 beat Establishment Labs' score of -0.10 indicating that Establishment Labs is being referred to more favorably in the news media.
Establishment Labs received 98 more outperform votes than Eargo when rated by MarketBeat users. Likewise, 61.88% of users gave Establishment Labs an outperform vote while only 60.87% of users gave Eargo an outperform vote.
Establishment Labs has higher revenue and earnings than Eargo. Establishment Labs is trading at a lower price-to-earnings ratio than Eargo, indicating that it is currently the more affordable of the two stocks.
Establishment Labs has a net margin of -53.12% compared to Establishment Labs' net margin of -263.14%. Establishment Labs' return on equity of -135.08% beat Eargo's return on equity.
Summary
Establishment Labs beats Eargo on 11 of the 17 factors compared between the two stocks.
Get Establishment Labs News Delivered to You Automatically
Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ESTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Establishment Labs Competitors List
Related Companies and Tools
